Literature DB >> 21266356

Cancer stem cell niche: the place to be.

Tijana Borovski1, Felipe De Sousa E Melo, Louis Vermeulen, Jan Paul Medema.   

Abstract

Tumors are being increasingly perceived as abnormal organs that, in many respects, recapitulate the outgrowth and differentiation patterns of normal tissues. In line with this idea is the observation that only a small fraction of tumor cells is capable of initiating a new tumor. Because of the features that these cells share with somatic stem cells, they have been termed cancer stem cells (CSC). Normal stem cells reside in a "stem cell niche" that maintains them in a stem-like state. Recent data suggest that CSCs also rely on a similar niche, dubbed the "CSC niche," which controls their self-renewal and differentiation. Moreover, CSCs can be generated by the microenvironment through induction of CSC features in more differentiated tumor cells. In addition to a role in CSC maintenance, the microenvironment is hypothesized to be involved in metastasis by induction of the epithelial-mesenchymal transition, leading to dissemination and invasion of tumor cells. The localization of secondary tumors also seems to be orchestrated by the microenvironment, which is suggested to form a premetastatic niche. Thus, the microenvironment seems to be of crucial importance for primary tumor growth as well as metastasis formation. Combined with its role in the protection of CSCs against genotoxic insults, these data strongly put forward the niche as an important target for novel therapies.

Entities:  

Mesh:

Year:  2011        PMID: 21266356     DOI: 10.1158/0008-5472.CAN-10-3220

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  190 in total

Review 1.  Head and neck cancer stem cells.

Authors:  S Krishnamurthy; J E Nör
Journal:  J Dent Res       Date:  2011-09-20       Impact factor: 6.116

Review 2.  Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.

Authors:  Qin Pan; Qiao Li; Shuang Liu; Ning Ning; Xiaolian Zhang; Yingxin Xu; Alfred E Chang; Max S Wicha
Journal:  Stem Cells       Date:  2015-05-13       Impact factor: 6.277

3.  Treatment of agarose-agarose RENCA macrobeads with docetaxel selects for OCT4(+) cells with tumor-initiating capability.

Authors:  Lawrence S Gazda; Prithy C Martis; Melissa A Laramore; Melissa A Bautista; Atira Dudley; Horatiu V Vinerean; Barry H Smith
Journal:  Cancer Biol Ther       Date:  2013-09-12       Impact factor: 4.742

4.  Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy.

Authors:  Bingxue Shang; Gaochuan Zhang; Yanyan Pan; Quansheng Zhou
Journal:  Cancer Microenviron       Date:  2012-05-17

5.  Cancer stem cells don't waste their time cleaning-low proteasome activity, a marker for cancer stem cell function.

Authors:  Kristiaan J Lenos; Louis Vermeulen
Journal:  Ann Transl Med       Date:  2016-12

Review 6.  Interaction between gastric cancer stem cells and the tumor microenvironment.

Authors:  Takatsugu Ishimoto; Hiroshi Sawayama; Hidetaka Sugihara; Hideo Baba
Journal:  J Gastroenterol       Date:  2014-03-21       Impact factor: 7.527

7.  Imaging Early Fate of Cancer Stem Cells in Mouse Hindlimbs with Sodium Iodide Symporter Gene and I-124 PET.

Authors:  Jin Won Park; Kyung-Ho Jung; Jin Hee Lee; Seung Hwan Moon; Young Seok Cho; Yearn Seung Choe; Kyung-Han Lee
Journal:  Mol Imaging Biol       Date:  2016-10       Impact factor: 3.488

8.  Cancer stem cells as a potential therapeutic target in thyroid carcinoma.

Authors:  Luisa Vicari; Cristina Colarossi; Dario Giuffrida; Ruggero De Maria; Lorenzo Memeo
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

Review 9.  Gastric cancer stem cells: a novel therapeutic target.

Authors:  Shree Ram Singh
Journal:  Cancer Lett       Date:  2013-04-10       Impact factor: 8.679

Review 10.  Perivascular stem cell niche in head and neck cancer.

Authors:  Kathryn E Ritchie; Jacques E Nör
Journal:  Cancer Lett       Date:  2012-07-25       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.